Literature DB >> 2115594

Further study of the increased mortality following transurethral prostatectomy: a chart-based analysis.

D J Malenka1, N Roos, E S Fisher, D McLerran, F S Whaley, M J Barry, R Bruskewitz, J E Wennberg.   

Abstract

Previous studies using large administrative databases found an elevated relative risk of reoperation and death after transurethral resection of the prostate compared to open prostatectomy. To investigate whether differences in case-mix unmeasured by administrative data explained this finding, we reviewed the charts of 485 patients who had undergone prostatectomy (236 open and 249 transurethral) at the Health Science Centre, Winnipeg, Manitoba, Canada between 1974 and 1980. Data from patient histories, physical examinations and laboratory evaluations were abstracted and used to control for case-mix in models comparing the rates of reoperation and mortality after transurethral versus open prostatectomy. Several models were specified. In all models the relative risk of dying after transurethral prostatectomy remained elevated (1.36 to 1.89), as did the risk for reoperation (3.62). A prospective trial is needed to establish the relative safety and effectiveness of transurethral and open prostatectomy.

Entities:  

Mesh:

Year:  1990        PMID: 2115594     DOI: 10.1016/s0022-5347(17)39416-8

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  7 in total

1.  Ascites following prostatectomy: a rare presentation of comorbid disease.

Authors:  Güven Aslan; Müjde Soytürk; Aykut Kefi; Ilhan Celebi; Hale Akpinar
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

2.  Comparing comorbid-illness indices assessing outcome variation: the case of prostatectomy.

Authors:  M A Krousel-Wood; A Abdoh; R Re
Journal:  J Gen Intern Med       Date:  1996-01       Impact factor: 5.128

3.  Improving the Safety of TURP.

Authors:  C G Roehrborn
Journal:  Rev Urol       Date:  2000

4.  On the status of the Prostate Disease Assessment Team.

Authors:  J E Wennberg
Journal:  Health Serv Res       Date:  1990-12       Impact factor: 3.402

Review 5.  Spontaneous versus precipitated AUR: the same?

Authors:  S Alan McNeil
Journal:  World J Urol       Date:  2006-09       Impact factor: 4.226

Review 6.  Comparison of the cost-effectiveness of various therapies for common prostatic disorders.

Authors:  E A Amin; M Amin
Journal:  Pharmacoeconomics       Date:  1992-05       Impact factor: 4.981

Review 7.  Changing therapeutic regimens in benign prostatic hyperplasia. Clinical and economic considerations.

Authors:  H J Stoevelaar; J McDonnell
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.